Association between dry eye, ophthalmic structures and fibromyalgia syndrome

News
Article

The authors examined vascular and neural structures in the eye, assessing the foveal avascular zone and choroidal thickness

A woman with neck pain and glasses at a computer. Concept image for dry eye and fibromyalgia. Image credit: ©peopleimages.com – stock.adobe.com

Tear break up time was significantly lower in patients with fibromyalgia, the study's authors found. Image credit: ©peopleimages.com – stock.adobe.com

A new Turkish study found “a relationship between dry eye, vascular changes and increased choroidal thickness with disease severity in female patients with fibromyalgia syndrome,” compared with healthy controls,1 according to first author Gülşah Çelik, MD, and colleagues. She is from the Department of Physical Medicine and Rehabilitation, Antalya City Hospital, Antalya, Turkey.

The participants in the study, which was conducted from January to October 2022, were 62 women with fibromyalgia syndrome and 60 healthy controls. The investigators evaluated the tear production and stability using the Schirmer and tear break-up time (TBUT) tests. Optical coherence tomography (OCT) and OCT angiography (OCTA) were performed to evaluate the vascular and choroidal structures.

Findings associated with fibromyalgia

The mean patient age was 43.11 ± 7.94 years.

The investigators found no significant difference in the results of the Schirmer tests between the patients and controls, but the TBUT was significantly lower in the fibromyalgia group (P < 0.001).

Imaging demonstrated the structural differences in the patients. OCTA showed significantly lower deep capillary plexus (DCP) values in the fibromyalgia group, with a weak negative correlation between DCP and disease severity (r = −0.227, P = 0.012). The foveal avascular zone (FAZ) non-flow, and choroidal thickness were significantly higher in the patients with fibromyalgia (P < 0.050), the authors reported.

“The study demonstrated a relationship between dry eye, vascular changes, and increased choroidal thickness with disease severity in female patients with fibromyalgia syndrome,” they commented.

They theorised that the reduction in the DCP values, along with the increases in the FAZ, non-flow and choroidal thickness, may be associated with the vascular and inflammatory processes involved in the pathogenesis of the fibromyalgia syndrome. In addition, they suggested that the decreased tear quality they observed may be due to autonomic nervous system dysfunction.

“In conclusion, we suggest that autonomic dysfunction and inflammation in the fibromyalgia syndrome may negatively affect retinal vascular structures and tear function,” they said.

Reference
Çelik G, Koldaş Doğan Ş, Bulut M, Hakan Büber, Doğan Durmaz. Evaluation of ophthalmic vascular and neural structures in female patients with fibromyalgia syndrome and their relationship with disease severity. Int Ophthalmol. 2025;45:123. https://doi.org/10.1007/s10792-025-03497-3

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.